Genomics Pioneer and Visionary Leader Joins BaseHealth to Run Commercial Growth and Long-Term Business Strategy
BaseHealth, the comprehensive predictive analytics company for healthcare, today announced that Ardy Arianpour has joined the company as Chief Business Officer. Arianpour, a genomics pioneer and visionary commercial leader with over 14 years of experience bringing innovative genomic technologies to market, was most recently Chief Commercial Officer of Pathway Genomics. He has held senior executive roles at a number of leading personalized medicine companies including Ambry Genetics and Cogenics, a division of Clinical Data.
Mr. Arianpour brings proven business experience and a long and successful track record of scaling genomics-based ventures to BaseHealth. He joins the company as it expands its offerings to larger organizations with an interest in accurately measuring and improving population health and helping individual members manage chronic conditions and disease risk.
“Our predictive analytics and risk assessment technology is revolutionizing the way we think about population health management,” said Prakash Menon, BaseHealth CEO. “As both a visionary and a seasoned executive in our industry, Ardy will help transform BaseHealth’s vision for a healthier population into a broad, industry-wide reality.”
The BaseHealth assessment engine leverages genomic data in combination with clinical and behavioral analysis to provide population health insights and personalized, evidence-based health assessments. The company’s predictive model is backed by more than five years of extensive disease research and built from validated data from over 30,000 peer-reviewed articles. It currently includes data on specific risk factors for more than 40 common complex diseases as well as information on 24 drug responses and 14 food responses, with more research being added to the platform regularly.
“I was drawn to the comprehensive approach BaseHealth takes to population health management. They’re the only company that is successfully leveraging genomic data in combination with traditional measures of risk to provide organizations with a comprehensive snapshot of disease risk for entire populations and single individuals,” said BaseHealth Chief Business Officer, Ardy Arianpour. “I’m excited to bring my years of experience to BaseHealth, especially at a time when the company is poised to significantly expand its offerings.”
Mr. Arianpour began his career in the field of genomics in the late 1990s at the prestigious Salk Institute. Obsessed with DNA, technology, and business, he has undergone almost every genetic test, including Illumina’s whole genome sequencing, so that he can help others understand the personal and commercial implications of this next generation of genetic information.
Mr. Arainpour holds a bachelor’s degree in biological sciences from the University of California, Irvine, and an MBA in strategic management from Marshall Goldsmith School of Management.